Amgen

Forecast & Rating34 analysts currently cover Amgen, with about 41.2% giving a positive rating — meaning they expect the stock to rise. The average price target is $388.48, about 12.2% downside from the current price of $442.45. Price targets range from $230.00 to $457.00 — a wide spread, showing clear disagreement over just how much Amgen can rise. Historically, about 92.0% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Amgen are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Sep 3, 2026; for reference only and not investment advice.